OBJECTIVE: This study seeks to determine which parental demographic and metabolic factors best correlate with fetal growth and body composition as estimated by ultrasound. STUDY DESIGN: Thirty-one gravid patients had ultrasound estimates of fetal anthropometry in mid-third trimester. These measurements included estimated fetal weight, abdominal subcutaneous fat, and/or thigh subcutaneous fat thickness. Independent variables included diagnosis of gestational diabetes, parental demographic factors, neonatal sex, and late gestation estimates of carbohydrate metabolism.
Abnormal fetal growth, whether macrosomia or growth restriction, has important implications relating to both short-term perinatal and possibly long-term metabolic outcome. The studies of Barker et al 1 have reported an increased adult risk of the insulin resistance syndrome, or syndrome X (ie, increased insulin resistance, hypertension, type 2 diabetes, and cardiovascular disease in growth-restricted infants). In addition to intrinsic/genetic factors, fetal in utero environment in particular, in utero metabolic environment may also affect the offspring's long-term growth and metabolism (the so-called metabolic imprinting effect). Pettit's long-term follow-up studies of the Pima Indians showed that a diagnosis of diabetes during gestation significantly increases the risk of both adolescent obesity and glucose intolerance, in contrast with that of children of the same woman when her glucose tolerance was normal during gestation. 2 Various factors have been associated with alterations in fetal growth. These include genetic factors such as neonatal sex and ethnic group; geographic factors such as altitude; maternal factors such as pre-gravid height, weight, and weight gain during gestation; and, to a lesser degree, paternal factors such as height and weight. [3] [4] [5] [6] [7] [8] In the assessment of fetal growth, the estimation of body composition has been a useful paradigm. As first hypothesized by Sparks, 9 fetal fat-free mass may represent growth regulated primarily by intrinsic/genetic factors, whereas fat mass may be more readily affected by environmental factors such as the maternal metabolic environment.
Maternal diabetes results in alterations of the fetoplacental metabolic environment, which may also affect fetal growth. In 1952, Pederson 10 hypothesized that maternal hyperglycemia results in increased maternal to fetal glucose transport with resultant fetal hyperinsulinemia and stimulation of fetal insulin production, as well as other growth factors. We, along with others, have recently reported that maternal whole body glucose insulin sensitivity has a strong inverse correlation with neonatal birth weight and body composition. Furthermore, decreased maternal glucose insulin sensitivity has been implicated in the pathophysiology of both type 2 and gestational diabetes mellitus (GDM). Hence, the purpose of this study was to relate the changes in various factors affecting fetal growth, including maternal insulin sensitivity to fetal body composition as estimated by ultrasound in the midthird trimester. [11] [12] [13] [14] We hypothesized that there is a stronger correlation of estimates of maternal carbohydrate metabolism with estimated fetal weight and fat mass at the time the measurements were obtained (34-36 weeks' gestation) than with estimates of fetal growth at birth. Because the metabolic environment in utero has great impact on growth and development postnatally, it is important to recognize abnormalities antenatally in order to affect them. Ultrasound is the major tool used in the antepartum period to identify abnormalities in growth. As such, it is important to define markers of abnormal growth on ultrasound and to assess what factors correlate best with these findings. Based on previous work by our group, we used subcutaneous fat measurements of the abdomen and thigh as predictors of fetal fat mass and estimated fetal weight as the best surrogate for fetal fat-free mass. 15 Since fat-free mass accounts for approximately 85% of birth weight, in this study we used estimated fetal weight as the best surrogate for fetal fat-free mass. We hypothesized that maternal metabolic factors had the strongest correlation with sonographic estimates of fetal growth, in particular, fetal adipose tissue.
Material and methods
These studies were performed in the General Clinical Research Centers at the Medical Center Hospital of Vermont and at MetroHealth Medical Center between 1988 and 1998. Some of the metabolic data from these subjects were included in reports that have been previously published. A detailed description of the subjects and methodologies used in these studies is included in the original publications. [11] [12] [13] [14] Written, informed consent was obtained from each subject before participation in the study protocol. Each protocol was approved by the hospital Institutional Review Board and the Scientific Review Committee of the General Clinical Research Center.
Thirty-one nonsmoking subjects were recruited to participate in a longitudinal study of carbohydrate metabolism before a planned pregnancy and in early (12-14 weeks) and late (34-36 weeks) gestation in the General Clinical Research Center. For the purposes of this study, only late gestation metabolic studies were used. Parental anthropometric data included maternal height, pregravid weight and weight gain up to the time of study in mid-third trimester, age, and parity. Paternal height and weight were also obtained by maternal history. Metabolic data included the following: (1) basal or fasting endogenous (primarily hepatic) glucose production by using a stable isotope of labeled glucose 6-6 2 H 2 glucose, (2) first (0-5 min) and second phase (6-60 min) insulin secretory response during an intravenous glucose tolerance test, and (3) insulin sensitivity as estimated by the hyperinsulinemic-euglycemic clamp, by using the glucose infusion rate needed to maintain euglycemia (90 mg/dL) during an insulin infusion of 40 mU/m 2 per minute. Insulin sensitivity index was defined as the glucose infusion rate necessary to maintain euglycemia during the clamp, plus residual endogenous glucose production during insulin infusion, divided by the mean insulin concentration achieved during the clamp. Maternal body composition was estimated with the use of hydrodensitometry. A diagnosis of GDM was made by using the criteria of Carpenter and Coustan. 16 Each subject had a first trimester ultrasound examination to confirm gestational age. The ultrasound examination for estimation of fetal growth and body composition was performed between 32 and 36 weeks of gestation. Two sonographers performed these ultrasounds, one at the Hospital of Vermont and one at MetroHealth Medical Center. At MetroHealth Medical Center the sonograms were made with the Acuson XPT using a 3.5 MHz linear transducer. Sonographic measurements consisted of fetal biparietal diameter, head circumference, abdominal circumference, anterior and lateral abdominal wall subcutaneous fat thicknesses, femur length, and anterior and lateral thigh subcutaneous fat thicknesses. Anterior and lateral abdominal wall thicknesses were measured at the level of the abdominal circumference in the anterior midline position from the inner to the outer aspect of the echogenic subcutaneous fat that surrounds the abdomen. Measurements of subcutaneous fat of the anterior and lateral thigh were made in similar fashion. The femur length was obtained by visualizing it longitudinally. It was then rotated 90°to obtain the cross-section of the thigh. Measurements were made at the midthigh. The number of ultrasound measurements obtained for estimates of abdominal subcutaneous fat were 4.5 ± 0.8 and the number of measurements of thigh subcutaneous fat were 4.7 ± 0.9 (mean ± SD). The coefficient of variation for the abdominal subcutaneous measure was 8.1% and for the thigh subcutaneous measures was 7.1%. Fetal weight was made with the Hadlock method. 17 Subcutaneous fat measurements of the abdomen and thigh were used to estimate fat mass as described by Bernstein and Catalano. 11 All 31 patients had assessment of estimated fetal weight. We attempted to perform fetal abdominal and thigh subcutaneous fat measurements on all subjects, but because of fetal position, only 30 patients had abdominal subcutaneous fat measurements, and 22 patients had thigh subcutaneous fat measurements. Twenty-one subjects had both abdominal and thigh subcutaneous fat measurements.
The data are expressed as mean ± SD. Sonographic estimates of fetal weight and abdominal and thigh subcutaneous fat thickness were used as dependent variables, and parental demographic, anthropometric, and metabolic measurements were used as independent variables using a univariate correlation. A P value <.05 was considered significant. Those significant univariate variables were then placed into a multivariate regression analysis. The software used for statistical analysis was Statview by Abacus Concepts, Berkeley, California.
Results
All subjects had singleton gestations, without medical or obstetric problems except for GDM. Nineteen of the subjects had normal glucose tolerance and 12 had GDM. Of the 12 subjects with GDM, 1 required insulin and 11 were diet controlled. Maternal and paternal demographic and anthropometric measurements for the 31 subjects are given in Table I . Subjects displayed a wide range of ages, heights, weights, weight gain, and paternal heights and weights. Thirty Caucasian women and 1 Hispanic woman were included.
The ultrasound measurements were performed at a mean gestational age of 34 weeks. The mean ± SD and range of the estimated fetal weight, abdominal and thigh subcutaneous fat measurements plus the sum of both the abdominal and thigh measurements are given in Table II. Estimates of maternal carbohydrate metabolism in late gestation are given in Table III . These include basal or fasting endogenous glucose production, both expressed in milligrams per minute. First and second phase insulin response, insulin sensitivity, and the insulin sensitivity index for the study subjects are also given in Table III .
Results of the univariate correlation analyses, shown in Table IV , include the following: estimated fetal weight had a significant correlation with basal hepatic glucose production (r = 0.515, P = .003), and with weight gain, (r = 0.459, P = .009). Abdominal subcutaneous fat thickness had significant correlation with maternal weight gain (r = 0.395, P = .027). Results of the best-fit stepwise regression analysis are given in Table V . The strongest predictor of estimated fetal weight using ultrasound was hepatic glucose production (R 2 = 0.24), followed by insulin sensitivity (R 2 = 0.03). Twenty-seven percent of the total variance (R 2 = 0.27) in sonographic estimated fetal weight was predicted with this model. The strongest predictors of sonographic abdominal subcutaneous fat measurement were maternal weight gain (R 2 = 0.15) and a diagnosis of GDM (R 2 = 0.10). Twenty-five percent of the total variance (R 2 = 0.25) in sonographic estimated fetal fat mass was predicted using this model. Thigh subcutaneous fat measurements did not significantly correlate with any independent factors. Adding both thigh and abdominal subcutaneous fat measurements together did not improve either the univariate or the multivariate model as compared with abdominal subcutaneous fat measurements alone.
We have also performed bestfit stepwise regression analysis with the 19 control subjects and 12 GDM subjects separately. For the control group, estimated fetal weight correlated best with maternal weight gain (R 2 = 0.26) and first phase insulin response (R 2 = 0.22). For the control group, abdominal fat thickness correlated best with paternal height (R 2 = 0.37). For the GDM group, estimated fetal weight correlated best with hepatic glucose production (late gestation) (R 2 = 0.28). For the GDM group, ab- dominal fat thickness did not correlate with any of the independent variables. Significance of these results is questionable because of the small number of subjects in the groups when analyzed separately.
Comment
The results of our study support our hypothesis that maternal metabolic factors have a significant correlation with ultrasound estimates of fetal growth. Our findings are similar to and expand on the findings of our previous study, which correlated estimates of maternal carbohydrate metabolism with birth weight at term. In those studies we reported that birth weight at term had the strongest correlation with maternal insulin sensitivity index in late gestation and maternal weight gain. The total R 2 was 0.48. 11 Ultrasound estimates of fetal weight are likewise inversely correlated with maternal insulin sensitivity and positively correlated with maternal weight gain. In our studies insulin sensitivity, second to basal endogenous, primarily hepatic glucose production, was significantly correlated with fetal weight in the multivariate stepwise analysis. Maternal weight gain, likewise secondary to basal hepatic glucose production, correlated with fetal weight on the univariate analysis.
Maternal weight gain, particularly in lean women, is a well-recognized factor in relation to fetal growth, as is the diagnosis of GDM. 18 Of interest, however, was the finding that in this study basal hepatic glucose production had the strongest correlation with estimated fetal weight (R 2 = 0.24). In clinical practice, fasting glucose concentrations are an estimate of fasting or basal hepatic glucose production. Furthermore, fasting glucose in the third trimester, as estimated by self-monitoring of blood glucose in women with GDM, was recently reported as having the strongest correlation with birth weight, in contrast to either preprandial or postprandial glucose values. * Hence fasting glucose concentrations may have a stronger correlation with the continuous variable of esti- Previously, insulin sensitivity has been reported by our group and others as having a significant inverse correlation with birth weight at term. The underlying premise being that if no abnormalities in factors such as uterine/placental blood flow exist, nutrient availability to the fetus is a function of maternal ability to metabolize and store nutrients, that is, insulin sensitivity. 11 The present study supports those findings, although only 3% of the variance in sonographically estimated fetal weight was accounted for by peripheral maternal insulin sensitivity. We speculate that the alterations in maternal basal hepatic glucose insulin sensitivity may also reflect alterations in other aspects of maternal metabolism, such as amino acid and lipid metabolism. Therefore factors affecting longterm maternal insulin sensitivity, such as diet and exercise, may need to be evaluated regarding their effect on fetal growth in relation to alterations in maternal insulin sensitivity. The long-term studies of Clapp 19 support the hypothesis that long-term exercise and glycemic index of the diet have a significant effect on fetal growth, possibly mediated through the effect on maternal insulin sensitivity.
The diagnosis of GDM and maternal weight gain were the only 2 variables included in the final model of the correlation with sonographically estimated fetal fat mass. However, they explained only 25% of the variance in estimated fetal fat mass. Therefore factors related to maternal metabolic environment, other than carbohydrate metabolism in late pregnancy alone, need further evaluation. We speculate that maternal lipid metabolism and possibly factors regulating placental leptin production may enhance our understanding of abnormal fetal growth and accretion of fetal adipose tissue in late gestation. Although GDM may include abnormalities in maternal lipid as well as carbohydrate metabolism, currently our clinical focus is directed primarily toward control of maternal glucose metabolism. The role of maternal lipid metabolism as it relates to fetal growth requires further investigation.
We recognize the limitations of our study design. Ultrasound estimation of fetal growth and body composition are not precise measures of these parameters. Based on the studies of Crane et al, 20 ultrasound estimates of fetal body composition using measurements of anthropometrics on ultrasound to determine fat-free mass and fat mass showed no significant difference in comparison to total body electrical conductivity measures of neonatal body composition (paired t test, P = .77). However, the 95% confidence intervals were wide, particularly for estimates of fetal fat mass. Furthermore, since fat-free mass accounts for approximately 85% of birth weight and explains approximately the same amount of the variance in birth weight, in this study we used estimated fetal weight as our best estimate of fatfree mass. Currently, ultrasound is the only imaging modality commonly used antenatally to predict abnormalities in fetal growth, although other methods such as magnetic resonance imaging are theoretically useful as a research tool. It will be important to determine whether the factors identified in these studies are confirmed as predictive of ultrasound growth; if so, they may be amenable to selective treatment modalities.
